Craniosynostosis in primary metabolic bone disorders: a single-institution experience
- PMID: 37420034
- DOI: 10.1007/s00381-023-06059-z
Craniosynostosis in primary metabolic bone disorders: a single-institution experience
Abstract
Purpose: The incidence of metabolic bone diseases in pediatric neurosurgical patients is rare. We examined our institutional experience of metabolic bone diseases along with a review of the literature in an effort to understand management for this rare entity.
Methods: Retrospective review of the electronic medical record database was performed to identify patients with primary metabolic bone disorders who underwent craniosynostosis surgery between 2011 and 2022 at a quaternary referral pediatric hospital. Literature review was conducted for primary metabolic bone disorders associated with craniosynostosis.
Results: Ten patients were identified, 6 of whom were male. The most common bone disorders were hypophosphatemic rickets (n = 2) and pseudohypoparathyroidism (n = 2). The median age at diagnosis of metabolic bone disorder was 2.02 years (IQR: 0.11-4.26), 2.52 years (IQR: 1.24-3.14) at craniosynostosis diagnosis, and 2.65 years (IQR: 0.91-3.58) at the time of surgery. Sagittal suture was most commonly fused (n = 4), followed by multi-suture craniosynostosis (n = 3). Other imaging findings included Chiari (n = 1), hydrocephalus (n = 1), and concurrent Chiari and hydrocephalus (n = 1). All patients underwent surgery for craniosynostosis, with the most common operation being bifronto-orbital advancement (n = 4). A total of 5 patients underwent reoperation, 3 of which were planned second-stage surgeries and 2 of whom had craniosynostosis recurrence.
Conclusions: We advocate screening for suture abnormalities in children with primary metabolic bone disorders. While cranial vault remodeling is not associated with a high rate of postoperative complications in this patient cohort, craniosynostosis recurrences may occur, and parental counseling is recommended.
Keywords: Craniosynostosis; Hypophosphatasia; Metabolic bone disorders; Rickets.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Di Rocco F, Rothenbuhler A, Cormier Daire V et al (2019) Craniosynostosis and metabolic bone disorder. A review. Neurochirurgie 65:258–263. https://doi.org/10.1016/j.neuchi.2019.09.008 - DOI - PubMed
-
- Bautista G (2021) Craniosynostosis: neonatal perspectives. NeoReviews 22:e250–e257. https://doi.org/10.1542/neo.22-4-e250 - DOI - PubMed
-
- Blount JP, Louis RG, Tubbs RS, Grant JH (2007) Pansynostosis: a review. Child’s Nerv Syst 23:1103–1109. https://doi.org/10.1007/s00381-007-0362-1 - DOI
-
- Charoenngam N, Cevik MB, Holick MF (2020) Diagnosis and management of pediatric metabolic bone diseases associated with skeletal fragility. Curr Opin Pediatr 32:560–573. https://doi.org/10.1097/MOP.0000000000000914 - DOI - PubMed
-
- Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L (2016) Pseudohypoparathyroidism - epidemiology, mortality and risk of complications. Clin Endocrinol (Oxf) 84:904–911. https://doi.org/10.1111/cen.12948 - DOI - PubMed